Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation
- 4 December 2007
- Vol. 26 (2) , 185-192
- https://doi.org/10.1016/j.vaccine.2007.10.066
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titerMalaria Journal, 2007
- Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus MacaquesJournal of Virology, 2007
- Successful parallel development and integration of a plasmid-based biologic, container/closure system and electrokinetic delivery deviceVaccine, 2006
- DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primatesVaccine, 2006
- Vaxfectin™ enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccinesVaccine, 2006
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infectionVaccine, 2004
- Enhancement of DNA vaccine potency in rhesus macaques by electroporationVaccine, 2004
- Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28—evaluation of homologous and heterologous antigen-delivery prime-boost strategyVaccine, 2004
- Induction of Plasmodium falciparum Transmission-Blocking Antibodies in Nonhuman Primates by a Combination of DNA and Protein ImmunizationsInfection and Immunity, 2004